Mode
Text Size
Log in / Sign up
N/A N=90 Randomized Triple-blind Treatment

Cognitive Remediation for Alcohol Use Disorder and Posttraumatic Stress Disorder

Alcohol Use Disorder · PTSD · Cognitive Dysfunction

Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: The Revised Hopkins Verbal Learning Test — 47.71; 44.14 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive Training (Behavioral); Cognitive training placebo control (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Jul 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
The Revised Hopkins Verbal Learning Test
47.71; 44.14
PRIMARY
The Wechsler Adult Intelligence Scale-IV Working Memory Index
102; 103.27
PRIMARY
The Conners' Continuous Performance Task II
47.92; 50.11
PRIMARY
The Color-Word Interference Test (DKEFS)
10.86; 10.55
PRIMARY
The Iowa Gambling Task
760.65; -371.40
PRIMARY
Trail Making Test (TMT) - Part B
51.00; 49.93
PRIMARY
The Wisconsin Card Sorting Test - Computer Version 4 Research Edition
48.65; 51.38
PRIMARY
The Tower Test (DKEFS)
11.83; 11.00
SECONDARY
Functional Status - Inventory of Psychosocial Functioning
40.41; 40.94
SECONDARY
PTSD Symptom Severity
36.04; 40.64

Summary

The project will examine whether a computerized neuroscience-based cognitive training program can improve cognitive functioning and recovery outcomes among Veterans with Alcohol Use Disorder and co-occurring PTSD. Information from this study will help determine the malleability of cognitive dysfunction, an established risk factor for poor recovery outcomes in this population. Improved functional outcomes can decrease risk of chronic impairment and ultimately help affected individuals live richer, more productive lives. Web-based treatment technologies may increase the reach and impact of treatment, and foster patient recovery in cases where staffing, space, acceptability of counseling, and transportation are barriers. Findings may also support expanding use of existing, highly-accessible cognitive remediation technologies to other vulnerable clinical populations.

Eligibility Criteria

Inclusion Criteria

  • Be a Veteran
  • Meet DSM-5 diagnostic criteria for current AUD
  • Meet DSM-5 criteria for current PTSD
  • Be willing to perform daily home-based computer exercises for 6 weeks

Exclusion Criteria

Individuals will be excluded based on evidence of the following:

  • History of, or current, psychotic disorder or Schizophrenia
  • Current scheduled (i.e., daily) prescribed use of cognitive enhancers (e.g., Memantine) or stimulants (e.g., Methylphenidate) that may enhance cognitive performance
  • Current severe traumatic brain injury (DoD TBI Screen 2)
  • Any type of dementia (Mini Mental Status Exam (MMSE) < 24), delirium or medical illnesses associated with potential cognitive issues (HIV, Hypothyroidism, B-12 deficiency)
  • Any level of mental retardation (Wechsler Test of Adult Reading WTAR)
  • Limited ability to speak/read/write/understand English (WTAR)
  • Inadequate vision or hearing
  • Active suicidal/homicidal intent
  • Self-report and collateral history from medical record/primary care physician/outpatient addiction treatment team will be used as necessary to determine inclusion and exclusion.
  • Suicidal and homicidal intent will be assessed in the context of a structured clinical interview.
  • In the unlikely event that respondents endorse active intent they will be referred immediately for treatment and will be excluded from the current study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02929979). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search